Table 3.
Urinary creatinine.
| Groups | 1st Week (mg/24 h.g) |
2nd Week (mg/24 h.g) |
6th Week (mg/24 h.g) |
|---|---|---|---|
| SPl (n = 10) | 0.243 ± 0.082 | 0.217 ± 0.034a | 0.240 ± 0.047 |
| SCr (n = 10) | 0.226 ± 0.038 | 0.284 ± 0.033A | 0.255 ± 0.036 |
| SCaf (n = 10) | 0.234 ± 0.027 | 0.208 ± 0.030a | 0.211 ± 0.030 |
| SCrCaf (n = 09) | 0.242 ± 0.020 | 0.245 ± 0.060 | 0.234 ± 0.011 |
| EPl (n = 09) | 0.231 ± 0.023 | 0.223 ± 0.040c | 0.223 ± 0.018 |
| ECr (n = 07) | 0.240 ± 0.050 | 0.301 ± 0.044A | 0.252 ± 0.015Bd |
| ECaf (n = 08) | 0.226 ± 0.023 | 0.208 ± 0.027c | 0.204 ± 0.021 |
| ECrCaf (n = 09) | 0.259 ± 0.014 | 0.288 ± 0.051bd | 0.263 ± 0.026d |
| Exercise Factor | |||
| Sedentary (n = 39) | 0.236 ± 0.046 | 0.238 ± 0.049 | 0.235 ± 0.040 |
| Exercised (n = 33) | 0.240 ± 0.032 | 0.258 ± 0.057 | 0.236 ± 0.030B |
| Supplementation Factor | |||
| Placebo (n = 19) | 0.236 ± 0.058 | 0.220 ± 0.036 | 0.232 ± 0.036 |
| Creatine (n = 17) | 0.233 ± 0.044 | 0.293 ± 0.039Aef | 0.253 ± 0.027Bf |
| Caffeine (n = 18) | 0.231 ± 0.025 | 0.208 ± 0.028A | 0.207 ± 0.026A |
| Creatine+Caffeine (n = 18) | 0.250 ± 0.025 | 0.267 ± 0.059ef | 0.248 ± 0.033f |
Data are mean ± SD. n, number of animals. Statistical significance (P < 0.05): A vs. 1st week; B vs. 2nd week (ANOVA Repeated Measures) for the same line. a vs. SCr; b vs. EPl; c vs. ECr; d vs. ECaf; e vs. Placebo; f vs. Caffeine (Tukey Test) for the same week. SPl, Sedentary placebo. SCr, sedentary creatine. SCaf, sedentary caffeine. SCrCaf, sedentary creatine plus caffeine. EPl, exercised placebo. ECr, exercised creatine. ECaf, exercised caffeine. ECrCaf, exercised creatine plus caffeine.